Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (421-430 of 551) with videos related to

Pageof 56
Sort By:
Oncotarget|September 30, 2015
Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncologySandip P Patel, Maria Schwaederle, Gregory A Daniels, et al.
The New England Journal of Medicine|May 28, 2004
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliterIan M Thompson, Donna K Pauler, Phyllis J Goodman, et al.
Journal of the National Cancer Institute|February 25, 2014
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer riskAlan R Kristal, Amy K Darke, J Steven Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinomaD M Shin, B S Glisson, F R Khuri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramificationsYoshitsugu Mitani, Pulivarthi H Rao, Sankar N Maity, et al.
Nutrition and Cancer|January 29, 2021
Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention TrialSusan Chadid, Xiaoling Song, Jeannette M Schenk, et al.
Molecular Cancer Therapeutics|March 12, 2009
Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cellsRalph G Zinner, Brittany L Barrett, Elmira Popova, et al.
Respiratory Research|April 19, 2015
A randomized controlled trial of vitamin E and selenium on rate of decline in lung functionPatricia A Cassano, Kristin A Guertin, Alan R Kristal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000
Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancerF R Khuri, R Lotan, B L Kemp, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancerJeri Kim, Peiyu Sun, Ying-Wai Lam, et al.
Pageof 56

Showing results (421-430 of 551) with videos related to

Sort By:
Pageof 56
Oncotarget|September 30, 2015
Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncologySandip P Patel, Maria Schwaederle, Gregory A Daniels, et al.
The New England Journal of Medicine|May 28, 2004
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliterIan M Thompson, Donna K Pauler, Phyllis J Goodman, et al.
Journal of the National Cancer Institute|February 25, 2014
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer riskAlan R Kristal, Amy K Darke, J Steven Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinomaD M Shin, B S Glisson, F R Khuri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramificationsYoshitsugu Mitani, Pulivarthi H Rao, Sankar N Maity, et al.
Nutrition and Cancer|January 29, 2021
Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention TrialSusan Chadid, Xiaoling Song, Jeannette M Schenk, et al.
Molecular Cancer Therapeutics|March 12, 2009
Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cellsRalph G Zinner, Brittany L Barrett, Elmira Popova, et al.
Respiratory Research|April 19, 2015
A randomized controlled trial of vitamin E and selenium on rate of decline in lung functionPatricia A Cassano, Kristin A Guertin, Alan R Kristal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000
Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancerF R Khuri, R Lotan, B L Kemp, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancerJeri Kim, Peiyu Sun, Ying-Wai Lam, et al.
Pageof 56